ADMA Biologics ADMA Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's preferred stock, par or stated value per share?
- ADMA Biologics (ADMA) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has ADMA Biologics's preferred stock, par or stated value per share changed year-over-year?
- ADMA Biologics's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for ADMA Biologics's preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), ADMA Biologics's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.